GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mycotopia Therapies Inc (OTCPK:TPIA) » Definitions » EV-to-FCF

Mycotopia Therapies (Mycotopia Therapies) EV-to-FCF : -9.80 (As of May. 26, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Mycotopia Therapies EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Mycotopia Therapies's Enterprise Value is $1.49 Mil. Mycotopia Therapies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.15 Mil. Therefore, Mycotopia Therapies's EV-to-FCF for today is -9.80.

The historical rank and industry rank for Mycotopia Therapies's EV-to-FCF or its related term are showing as below:

TPIA' s EV-to-FCF Range Over the Past 10 Years
Min: -67.3   Med: 15.77   Max: 3032.68
Current: -9.8

During the past 6 years, the highest EV-to-FCF of Mycotopia Therapies was 3032.68. The lowest was -67.30. And the median was 15.77.

TPIA's EV-to-FCF is ranked worse than
100% of 361 companies
in the Healthcare Providers & Services industry
Industry Median: 19.29 vs TPIA: -9.80

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-26), Mycotopia Therapies's stock price is $0.04. Mycotopia Therapies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.090. Therefore, Mycotopia Therapies's PE Ratio for today is At Loss.


Mycotopia Therapies EV-to-FCF Historical Data

The historical data trend for Mycotopia Therapies's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mycotopia Therapies EV-to-FCF Chart

Mycotopia Therapies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial 19.23 -739.59 -129.42 -4.48 -9.82

Mycotopia Therapies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.65 -2.46 -8.84 -9.82 -17.65

Competitive Comparison of Mycotopia Therapies's EV-to-FCF

For the Medical Care Facilities subindustry, Mycotopia Therapies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mycotopia Therapies's EV-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mycotopia Therapies's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Mycotopia Therapies's EV-to-FCF falls into.



Mycotopia Therapies EV-to-FCF Calculation

Mycotopia Therapies's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1.490/-0.152
=-9.80

Mycotopia Therapies's current Enterprise Value is $1.49 Mil.
Mycotopia Therapies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mycotopia Therapies  (OTCPK:TPIA) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Mycotopia Therapies's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.04/-0.090
=At Loss

Mycotopia Therapies's share price for today is $0.04.
Mycotopia Therapies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.090.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Mycotopia Therapies EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Mycotopia Therapies's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Mycotopia Therapies (Mycotopia Therapies) Business Description

Traded in Other Exchanges
N/A
Address
18851 NE 29th Avenue, Suite 700, Aventura, FL, USA, 33180
Mycotopia Therapies Inc provides psychedelic therapies through technology-focused, data-driven, and medical-based solutions for people dealing with anxiety, depression, bipolar disorders, PTSD, ADHD, autism, and addictions.
Executives
Mark D. Williams director, 10 percent owner, officer: President, CEO & CFO 480 22ND STREET, BOX 2, HEYBURN ID 83336
Gibson Colin director, 10 percent owner, officer: Vice President 480 22ND STREET, BOX 2, HEYBURN ID 83336

Mycotopia Therapies (Mycotopia Therapies) Headlines

From GuruFocus

Ehave Issues Shareholder Letter and Provides Corporate Update

By GuruFocusNews GuruFocusNews 01-31-2022